|
業務類別
|
Medical Devices |
|
業務概覽
|
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America. |
| 公司地址
| 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144 |
| 電話號碼
| +1 770 419-3355 |
| 傳真號碼
| +1 770 590-3753 |
| 公司網頁
| https://www.artivion.com |
| 員工數量
| 1800 |
| Ms. Amy D. Horton, C.P.A. |
Vice President and Chief Accounting Officer |
-- |
18/02/2026 |
| Mr. Lance A. Berry, C.P.A. |
Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer |
美元 500.00K |
18/02/2026 |
| Mr. Florian Tyrs |
Vice President, Global Operations |
-- |
18/02/2026 |
| Mr. James Patrick Mackin |
President, Chief Executive Officer and Chairman of the Board |
美元 806.90K |
18/02/2026 |
| Ms. Jean F. Holloway, Esq. |
Senior Vice President, General Counsel, Chief Compliance Officer and Secretary |
美元 425.64K |
18/02/2026 |
| Mr. John E. Davis |
Chief Commercial Officer |
美元 406.86K |
18/02/2026 |
| Dr. Robert C. Thomson, PhD |
Vice President, Research and Development |
-- |
18/02/2026 |
| Mr. Matthew A. Getz |
Vice President, Human Resources |
-- |
18/02/2026 |
| Ms. Rochelle L. Maney |
Vice President, Quality Systems and Tissue Quality |
-- |
18/02/2026 |
| Dr. Marshall S. Stanton, M.D. |
Senior Vice President, Clinical Research and Chief Medical Officer |
美元 409.59K |
18/02/2026 |
| Mr. Andrew M. Green |
Senior Vice President, Regulatory and Quality |
-- |
18/02/2026 |
|
|
| Mr. Daniel J. Bevevino |
Independent Director |
18/02/2026 |
| Mr. James Patrick Mackin |
President, Chief Executive Officer and Chairman of the Board |
18/02/2026 |
| Mr. Jeffrey H. Burbank |
Lead Independent Director |
18/02/2026 |
| Mr. Jon W. Salveson |
Independent Director |
18/02/2026 |
| Mr. Thomas F. Ackerman |
Independent Director |
18/02/2026 |
| Ms. Elizabeth A. Hoff |
Independent Director |
18/02/2026 |
| Mr. James W. Bullock |
Independent Director |
18/02/2026 |
| Ms. Marna P. Borgstrom |
Independent Director |
18/02/2026 |
| Mr. Anthony B. Semedo |
Independent Director |
18/02/2026 |
|
|
|
|
